Int J Clin Pract Suppl. 2011 Jan;(169):11-8. doi: 10.1111/j.1742-1241.2010.02600.x.
Current management approaches to portopulmonary hypertension.
Savale L, O'Callaghan DS, Magnier R, Le Pavec J, Hervé P, Jaïs X, Seferian A, Humbert M, Simonneau G, Sitbon O.
Presse Med. 2011 Jan;40(1 Pt 2):e65-78. Epub 2011 Jan 5.
Pulmonary veno-occlusive disease: the bête noire of pulmonary hypertension in connective tissue diseases?
O'Callaghan DS, Dorfmuller P, Jaïs X, Mouthon L, Sitbon O, Simonneau G, Humbert M, Montani D.
J Rheumatol. 2011 Nov;38(11):2419-27. Epub 2011 Oct 1.
Analysis of the Validation Status of Quality of Life and Functional Disability Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Results of a Systematic Literature Analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS).
Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O.
Chest. 2011 Oct;140(4):1016-24. Epub 2011 Apr 7.
Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease.
Launay D, Humbert M, Berezne A, Cottin V, Allanore Y, Couderc LJ, Bletry O, Yaici A, Hatron PY, Mouthon L, Le Pavec J, Clerson P, Hachulla E.
N Engl J Med. 2011 Jul 7;365(1):44-53.
A hemodynamic study of pulmonary hypertension in sickle cell disease.
Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.
J Pediatr Surg. 2011 Nov;46(11):2190-4.
Left pulmonary artery sling with right lung aplasia.
Pierron C, Sigal-Cinqualbre A, Lambert V, Le Bret E.
Left pulmonary artery sling with right lung aplasia.
Pierron C, Sigal-Cinqualbre A, Lambert V, Le Bret E.
Eur Respir J. 2012 Jun;39(6):1405-14. Epub 2011 Oct 17.
Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
Dib H, Tamby MC, Bussone G, Regent A, Berezné A, Lafine C, Broussard C, Simonneau G, Guillevin L, Witko-Sarsat V, Humbert M, Mouthon L
Chest. 2011 Oct;140(4):1066-8.
Pulmonary arterial hypertension in a patient with cowden syndrome and anorexigen exposure.
Natali D, Girerd B, Montani D, Soubrier F, Simonneau G, Humbert M, Sitbon O
Circulation. 2011 Nov 1;124(18):1973-81.
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Results From an International Prospective Registry.
Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G
J Rheumatol. 2011 Nov;38(11):2419-2427. Epub 2011 Oct 1.
Analysis of the Validation Status of Quality of Life and Functional Disability Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Results of a Systematic Literature Analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS).
Kowal-Bielecka O, Avouac J, Pittrow D, Huscher D, Behrens F, Denton CP, Foeldvari I, Humbert M, Matucci-Cerinic M, Nash P, Opitz CF, Rubin LJ, Seibold JR, Strand V, Furst DE, Distler O; for the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis.